SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2004 SESSION
Be it enacted by the General Assembly of Virginia:
1. That § 32.1-65, as it is currently effective and as it may become effective, of the Code of Virginia is amended and reenacted as follows:
§ 32.1-65. (Effective until contingency met /- See note) Infants to be subjected to tests.
In order to prevent mental retardation, permanent disability or death, every
infant who is born in this Commonwealth shall be subjected to a screening test
for biotinidase deficiency, phenylketonuria, hypothyroidism, homocystinuria,
galactosemia, congenital adrenal hyperplasia, and Maple Syrup Urine Disease,
and each infant determined at risk shall be subject to a screening test for
sickle cell diseases. Any infant whose parent or guardian objects thereto on
the grounds that such test conflicts with his religious practices or tenets
shall not be required to receive a screening test. The physician, nurse or
certified nurse midwife in charge of the delivery of a baby or, if none,
the first attending physician infant's care after delivery shall cause such
test to be performed. The screening tests shall be performed by the Division of Consolidated
Laboratory Services or any other laboratory the Department of Health has contracted with to
provide this service.
The program for screening infants for sickle cell diseases shall be conducted in addition to the programs provided for in Article 8 (§ 32.1-68 et seq.) of this chapter.
§ 32.1-65. (For contingent effective date /- See note) Infants to be subjected to tests.
In order to prevent mental retardation, permanent disability or death, every
infant who is born in this Commonwealth shall be subjected to a screening test
for biotinidase deficiency, phenylketonuria, hypothyroidism, homocystinuria,
galactosemia, congenital adrenal hyperplasia, medium-chain acyl-CoA
dehydrogenase (MCAD or MCADH) deficiency, and Maple Syrup Urine Disease, and
each infant determined at risk shall be subject to a screening test for sickle
cell diseases. Any infant whose parent or guardian objects thereto on the
grounds that such test conflicts with his religious practices or tenets shall
not be required to receive a screening test. The physician, nurse or certified
nurse midwife in charge of the delivery of a baby or, if none, the first
attending physician infant's care after delivery shall cause such test to be
performed. The screening tests shall be performed by the Division of Consolidated Laboratory
Services or any other laboratory the Department of Health has contracted with to provide this
service.
The program for screening infants for sickle cell diseases shall be conducted in addition to the programs provided for in Article 8 (§ 32.1-68 et seq.) of this chapter.